We are live on
!
Find out more
PAI
Palo Alto Investors Portfolio holdings
AUM
$654M
1-Year Est. Return
77.8%
This Fund
S&P 500
This Quarter
Est. Return
+25.06%
1 Year Est. Return
+77.8%
3 Year Est. Return
+127.05%
5 Year Est. Return
+199.24%
10 Year Est. Return
+2,229.57%
AUM
$1.21B
AUM Growth
+$138M
(+13%)
Cap. Flow
-$5.83M
Cap. Flow
% of AUM
-0.48%
Top 10 Holdings %
Top 10 Hldgs %
71.65%
Holding
41
New
7
Increased
11
Reduced
13
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
+$15.7M |
| 2 |
ITMN
INTERMUNE INC
ITMN
|
+$13.3M |
| 3 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
+$11.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$2.86M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$2.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBX
CYBERONICS INC
CYBX
|
+$16.1M |
| 2 |
VPHM
VIROPHARMA INC
VPHM
|
+$14.5M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$13.4M |
| 4 |
STAAR Surgical
STAA
|
+$10M |
| 5 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$3.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
26
DELISTED
Amicus Therapeutics
FOLD
| $8.22M | 0.68% |
3,971,576
-37,000
| -0.9% | -$92.5K |
|
27
Insmed
INSM
$28.9B
| $6.03M | 0.5% |
316,699
+24,500
| +8% | +$466K |
|
|
SPPI
28
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.15M | 0.26% |
402,285
| – | – |
|
|
RVNC
29
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.89M | 0.24% |
+91,669
| New | +$2.86M |
|
30
Cytokinetics
CYTK
$10.5B
| $2.35M | 0.19% |
247,186
+14,378
| +6% | +$130K |
|
|
AVEO
31
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.14M | 0.18% |
142,917
| – | – |
|
|
HPTX
32
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $1.62M | 0.13% |
62,700
| – | – |
|
|
XOMA
33
DELISTED
Xoma
XOMA
| $1.33M | 0.11% |
12,805
| – | – |
|
34
Geron
GERN
$1.01B
| $1.06M | 0.09% |
+536,723
| New | +$2.14M |
|
|
SPHS
35
DELISTED
Sophiris Bio, Inc.
SPHS
| $975K | 0.08% |
292,900
| – | – |
|
36
Align Technology
ALGN
$12.4B
| $403K | 0.03% |
+7,788
| New | +$436K |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $362K | 0.03% |
5,180
| – | – |
|
|
SHPG
38
DELISTED
Shire pic
SHPG
| $267K | 0.02% |
+1,800
| New | +$278K |
|
39
Gilead Sciences
GILD
$168B
| $255K | 0.02% |
+3,600
| New | +$282K |
|
|
VPHM
40
DELISTED
VIROPHARMA INC
VPHM
| – | – |
-290,916
| Closed | -$14.5M |
|
Similar funds
AG
BL
PIM
ACA
PCM
HCM
ACM
DC
Palo Alto Investors's Q1 2014 Portfolio in Review
As of Q1 2014, Palo Alto Investors held 41 positions worth $1.21B, up 13% from $1.07B the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Palo Alto Investors's Q1 2014 filing shows 7 new, 11 increased, 13 reduced and 2 closed positions. Its largest new stake was Eiger BioPharmaceuticals, Inc.: 3,314 shares worth $17.8M. The largest sale was CYBERONICS INC, an estimated $16.1M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 44% a quarter earlier.
- Palo Alto Investors's largest Q1 2014 buy was Eiger BioPharmaceuticals, Inc.: 3,314 shares worth $17.8M.
- Palo Alto Investors added most to INTERMUNE INC in Q1 2014, an estimated $13.3M increase.
- Palo Alto Investors's biggest Q1 2014 reduction was CYBERONICS INC, cutting an estimated $16.1M.
- Palo Alto Investors fully exited VIROPHARMA INC in Q1 2014, selling an estimated $14.5M.
- Palo Alto Investors's ten largest holdings make up 72% of its $1.21B portfolio in Q1 2014.
- Palo Alto Investors opened 7 new positions and closed 2 in Q1 2014.
- Palo Alto Investors's portfolio value rose 13% quarter-over-quarter to $1.21B.
Based on Palo Alto Investors's 13F filing for Q1 2014, filed 15 May 2014.